Sun Pharma down as Taro Q4 margins decline

Tata Motors, SBI, TCS, Sun Pharma, Infosys, ITC and Bharti Airtel were the names weighing down the indices. email this article Subject line: Your Email: Send me a copy: Recipients Id: Type address separated by commas Enter the characters shown in the image.

We said, "Bias is negative... Grey channel at 19950 ... consider 19950 as crucial ..." Index broke the Grey channel on weak Global cues, and shaved off a hefty 388 pts or nearly 2% as a result. All sectors proved losers, but Realty and Capital Goods Indexes ...

The BSE Sensex is up 55.85 points or 0.28% at 19730.18. Drug major Sun Pharma fell more than two percent after its subsidiary Taro's operating profit margin declined 740 basis points year-on-year to 38.2 percent during the fourth quarter.

Following technical calls have been recommended by ICICIdirect for intra-day trade on May 24, 2013: 1. Sun Pharma 'Buy' above Rs 1,009 with target of Rs 1,025-1,033 higher and stop loss Rs 1,001. Comment: Recent trading range breakout in the daily chart and ...

Sun Pharmaceutical Industries Ltd has announced that the High Court of Gujarat at Ahmedabad and High Court of Mumbai, at their respective hearing held both on May 03, 2013 approved the Scheme of Arrangement between Sun Pharmaceutical Industries ...

Buying opportunity is seen in Sun Pharma, says Sudarshan Sukhani of s2analytics.com.

Pankaj Jain of Sunteck Wealthmax is bullish on HPCL and Sun Pharma Advanced, while he is bearish on India Cement and Opto Circuits.

While the has notified the (DPCO) last week, which will bring prices of 348 essential medicines under control, and, in turn, impact the sales and margins of major pharmaceutical companies, data compiled by pharma research firm AIOCD AWACS shows that ...

The Nifty is trading in a tight 30 points range. Defensives like Dr Reddy's Laboratories and Sun Pharmaceuticals are up over 2%. At 11:22 AM,the Sensex is trading at 20170, up 58 points, while the Nifty isup 13 points at 6,127. The BSE Small-Cap and ...